{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T16:40:10Z","timestamp":1744648810286,"version":"3.40.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Joint Funds for the Innovation of Science and Technology","award":["2019Y9052","2023Y9198","2023Y9198","2019Y9052"],"award-info":[{"award-number":["2019Y9052","2023Y9198","2023Y9198","2019Y9052"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-97333-4","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T14:32:29Z","timestamp":1744641149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and validation of LY6H and GRM3 as candidate biomarkers for Glioma-related epilepsy"],"prefix":"10.1038","volume":"15","author":[{"given":"Zhenpan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhuang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caihou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"97333_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.02.002","volume":"476","author":"S Xu","year":"2020","unstructured":"Xu, S. et al. Immunotherapy for glioma: current management and future application. Cancer Lett. 476, 1\u201312 (2020).","journal-title":"Cancer Lett."},{"issue":"8","key":"97333_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"A Louis D N, Perry","year":"2021","unstructured":"Louis D N, Perry, A. et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 23(8), 1231\u20131251 (2021).","journal-title":"Neuro Oncol."},{"key":"97333_CR3","doi-asserted-by":"publisher","first-page":"550353","DOI":"10.3389\/fonc.2020.550353","volume":"10","author":"G You","year":"2020","unstructured":"You, G. & Sha, Z. Clinical diagnosis and perioperative management of Glioma-Related epilepsy. Front. Oncol. 10, 550353 (2020).","journal-title":"Front. Oncol."},{"key":"97333_CR4","doi-asserted-by":"publisher","first-page":"890857","DOI":"10.3389\/fneur.2022.890857","volume":"13","author":"G Pauletto","year":"2022","unstructured":"Pauletto, G. et al. Pre- and Post-surgical poor seizure control as hallmark of malignant progression in patients with glioma??. Front. Neurol. 13, 890857 (2022).","journal-title":"Front. Neurol."},{"issue":"1","key":"97333_CR5","first-page":"5","volume":"10","author":"L Yogendran","year":"2023","unstructured":"Yogendran, L. & Rudolf, M. Navigating disability insurance in the American healthcare system for the low-grade glioma patient. Neurooncol Pract. 10(1), 5\u201312 (2023).","journal-title":"Neurooncol Pract."},{"issue":"5","key":"97333_CR6","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1007\/s00415-021-10845-7","volume":"269","author":"E Mazzucchi","year":"2022","unstructured":"Mazzucchi, E. et al. The persistence of seizures after tumor resection negatively affects survival in low-grade glioma patients: a clinical retrospective study. J. Neurol. 269(5), 2627\u20132633 (2022).","journal-title":"J. Neurol."},{"issue":"3","key":"97333_CR7","first-page":"209","volume":"6","author":"M Santos-Pinheiro F, Park","year":"2019","unstructured":"Santos-Pinheiro F, Park, M. et al. Seizure burden pre- and postresection of low-grade gliomas as a predictor of tumor progression in low-grade gliomas. Neurooncol Pract. 6(3), 209\u2013217 (2019).","journal-title":"Neurooncol Pract."},{"issue":"10","key":"97333_CR8","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nm.2453","volume":"17","author":"S C Buckingham","year":"2011","unstructured":"Buckingham, S. C. et al. Glutamate release by primary brain tumors induces epileptic activity. Nat. Med. 17(10), 1269\u20131274 (2011).","journal-title":"Nat. Med."},{"key":"97333_CR9","doi-asserted-by":"crossref","unstructured":"Saviuk, M. et al. Unexplained causes of Glioma-Associated epilepsies: A review of theories and an area for research. Cancers (Basel), 15(23). (2023).","DOI":"10.3390\/cancers15235539"},{"issue":"10","key":"97333_CR10","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1158\/1535-7163.MCT-19-0929","volume":"19","author":"T Takayasu","year":"2020","unstructured":"Takayasu, T. et al. Ion channels and their role in the pathophysiology of gliomas. Mol. Cancer Ther. 19(10), 1959\u20131969 (2020).","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"97333_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/neuonc\/noad154","volume":"26","author":"S Avila E K, Tobochnik","year":"2024","unstructured":"Avila E K, Tobochnik, S. et al. Brain tumor-related epilepsy management: A society for Neuro-oncology (SNO) consensus review on current management. Neuro Oncol. 26(1), 7\u201324 (2024).","journal-title":"Neuro Oncol."},{"issue":"11","key":"97333_CR12","doi-asserted-by":"publisher","first-page":"e50122","DOI":"10.1371\/journal.pone.0050122","volume":"7","author":"D O U W L Van Dellen E","year":"2012","unstructured":"Van Dellen E, D. O. U. W. L. et al. MEG network differences between low- and high-grade glioma related to epilepsy and cognition. PLoS One 7(11), e50122 (2012).","journal-title":"PLoS One"},{"key":"97333_CR13","doi-asserted-by":"publisher","first-page":"106430","DOI":"10.1016\/j.eplepsyres.2020.106430","volume":"166","author":"S Shen","year":"2020","unstructured":"Shen, S. et al. Correlation of preoperative seizures with a wide range of tumor molecular markers in gliomas: an analysis of 442 glioma patients from China. Epilepsy Res. 166, 106430 (2020).","journal-title":"Epilepsy Res."},{"key":"97333_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.seizure.2019.05.018","volume":"69","author":"A M Feyissa","year":"2019","unstructured":"Feyissa, A. M. et al. Potential influence of IDH1 mutation and MGMT gene promoter methylation on glioma-related preoperative seizures and postoperative seizure control . Seizure 69, 283\u2013289 (2019).","journal-title":"Seizure"},{"issue":"6","key":"97333_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41580-020-0231-2","volume":"21","author":"I Bludau","year":"2020","unstructured":"Bludau, I. Proteomic and interactomic insights into the molecular basis of cell functional diversity. Nat. Rev. Mol. Cell. Biol. 21(6), 327\u2013340 (2020).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"97333_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1146\/annurev-anchem-071213-020216","volume":"7","author":"Z Zhang","year":"2014","unstructured":"Zhang, Z. et al. High-throughput proteomics. Annu. Rev. Anal. Chem. (Palo Alto Calif) 7, 427\u2013454 (2014).","journal-title":"Annu. Rev. Anal. Chem. (Palo Alto Calif)"},{"key":"97333_CR17","doi-asserted-by":"crossref","unstructured":"Park, M. et al. The role of extracellular vesicles in optic nerve injury: neuroprotection and mitochondrial homeostasis. Cells, 11(23). (2022).","DOI":"10.3390\/cells11233720"},{"issue":"1","key":"97333_CR18","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1038\/s41467-022-33282-0","volume":"13","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals new therapeutic strategies. Nat. Commun. 13(1), 5723 (2022).","journal-title":"Nat. Commun."},{"issue":"2","key":"97333_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5114\/fn.2022.118183","volume":"60","author":"A Sejda","year":"2022","unstructured":"Sejda, A. & Grajkowska, W. WHO CNS5 2021 classification of gliomas: a practical review and road signs for diagnosing pathologists and proper patho-clinical and neuro-oncological Cooperation. Folia Neuropathol. 60(2), 137\u2013152 (2022).","journal-title":"Folia Neuropathol."},{"issue":"1","key":"97333_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41467-022-35740-1","volume":"14","author":"R Lou","year":"2023","unstructured":"Lou, R. et al. Benchmarking commonly used software suites and analysis workflows for DIA proteomics and phosphoproteomics. Nat. Commun. 14(1), 94 (2023).","journal-title":"Nat. Commun."},{"issue":"7","key":"97333_CR21","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"B Ritchie M E, Phipson","year":"2015","unstructured":"Ritchie M E, Phipson, B. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43(7), e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"97333_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 9, 559 (2008).","journal-title":"BMC Bioinform."},{"issue":"3","key":"97333_CR23","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov. (Camb) 2(3), 100141 (2021).","journal-title":"Innov. (Camb)"},{"key":"97333_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/978-1-0716-3327-4_32","volume":"2690","author":"A Majeed","year":"2023","unstructured":"Majeed, A. Protein-Protein interaction network exploration using cytoscape. Methods Mol. Biol. 2690, 419\u2013427 (2023).","journal-title":"Methods Mol. Biol."},{"issue":"Suppl 4(Suppl 4","key":"97333_CR25","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"C H Chin","year":"2014","unstructured":"Chin, C. H. et al. CytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 8(Suppl 4(Suppl 4), S11 (2014).","journal-title":"BMC Syst. Biol."},{"issue":"1","key":"97333_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"97333_CR27","doi-asserted-by":"crossref","unstructured":"Villanueva R A M & Chen Z J. ggplot2: Elegant Graphics for Data Analysis [Z] (Taylor & Francis, 2019).","DOI":"10.1080\/15366367.2019.1565254"},{"key":"97333_CR28","doi-asserted-by":"crossref","unstructured":"Tay, J. K. & Narasimhan, B. Hastie T. Elastic net regularization paths for all generalized linear models. J. Stat. Softw., 106. (2023).","DOI":"10.18637\/jss.v106.i01"},{"key":"97333_CR29","doi-asserted-by":"crossref","unstructured":"Kuhn M. Building predictive models in R using the caret package. J. Stat. Softw. 28, 1\u201326 (2008).","DOI":"10.18637\/jss.v028.i05"},{"issue":"Mar","key":"97333_CR30","first-page":"1157","volume":"3","author":"I Guyon","year":"2003","unstructured":"Guyon, I. An introduction to variable and feature selection. J. Mach. Learn. Res. 3(Mar), 1157\u20131182 (2003).","journal-title":"J. Mach. Learn. Res."},{"key":"97333_CR31","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1023\/A:1012487302797","volume":"46","author":"I Guyon","year":"2002","unstructured":"Guyon, I. & Weston, J. Gene selection for cancer classification using support vector machines. Mach. Learn. 46, 389\u2013422 (2002).","journal-title":"Mach. Learn."},{"key":"97333_CR32","unstructured":"Dimitriadou, E. et al. Package \u2018e1071\u2019. R Software package, avaliable at http:\/\/cran rproject org\/web\/packages\/e1071\/index html, (2009)."},{"key":"97333_CR33","first-page":"1439","volume":"3","author":"J Weston","year":"2003","unstructured":"Weston, J. et al. Use of the zero norm with linear models and kernel methods. J. Mach. Learn. Res. 3, 1439\u20131461 (2003).","journal-title":"J. Mach. Learn. Res."},{"key":"97333_CR34","unstructured":"Torgo L. Package\u2019DMwR\u2019. Comprehensive R Archive Network, (2013)."},{"key":"97333_CR35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11749-016-0481-7","volume":"25","author":"G Biau","year":"2016","unstructured":"Biau, G., Scornet E. A random forest guided tour. Test 25, 197\u2013227 (2016).","journal-title":"Test"},{"key":"97333_CR36","unstructured":"Jethani, N. et al. Fastshap: Real-time shapley value estimation; proceedings of the International conference on learning representations, F, [C]. (2021)."},{"key":"97333_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. & Turck, N. pROC: an open-source package for R and S + to analyze and compare ROC curves. BMC Bioinform. 12, 77 (2011).","journal-title":"BMC Bioinform."},{"key":"97333_CR38","unstructured":"Harrell F E. Regression modeling strategies. R package version. : 6.2-0. (2012)."},{"issue":"1","key":"97333_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Chinese glioma genome atlas (CGGA): A comprehensive resource with functional genomic data from Chinese glioma Patients. Genomics Proteom. Bioinf. 19 (1), 1\u201312 (2021).","journal-title":"Genomics Proteom. Bioinf."},{"issue":"10","key":"97333_CR40","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein, J. N. et al. The cancer genome atlas Pan-Cancer analysis project. Nat. Genet. 45 (10), 1113\u20131120 (2013).","journal-title":"Nat. Genet."},{"issue":"6","key":"97333_CR41","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.biopsych.2021.02.970","volume":"90","author":"S Dogra","year":"2021","unstructured":"Dogra, S. et al. Activating mGlu(3) metabotropic glutamate receptors rescues Schizophrenia-like cognitive deficits through metaplastic adaptations within the hippocampus. Biol. Psychiatry 90(6), 385\u2013398 (2021).","journal-title":"Biol. Psychiatry"},{"key":"97333_CR42","doi-asserted-by":"publisher","first-page":"722592","DOI":"10.3389\/fnins.2021.722592","volume":"15","author":"M Song","year":"2021","unstructured":"Song, M. et al. Genome-Wide Meta-Analysis identifies two novel risk loci for epilepsy. Front. Neurosci. 15, 722592 (2021).","journal-title":"Front. Neurosci."},{"issue":"6","key":"97333_CR43","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1021\/acs.jmedchem.7b01481","volume":"61","author":"JA Monn","year":"2018","unstructured":"Monn, J. A. et al. Synthesis and Pharmacological characterization of C4(\u03b2)-Amide-Substituted 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1 S,2 S,4 S,5 R,6 S)-2-Amino-4-[(3-methoxybenzoyl)amino]bicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY2794193), a highly potent and selective mGlu(3) receptor agonist. J. Med. Chem. 61(6), 2303\u20132328 (2018).","journal-title":"J. Med. Chem."},{"issue":"1","key":"97333_CR44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/1570159X20666220509160511","volume":"21","author":"R Celli","year":"2023","unstructured":"Celli, R. et al. mGlu3 metabotropic glutamate receptors as a target for the treatment of absence epilepsy: preclinical and human genetics data. Curr. Neuropharmacol. 21(1), 105\u2013118 (2023).","journal-title":"Curr. Neuropharmacol."},{"key":"97333_CR45","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3389\/fneur.2020.01006","volume":"11","author":"DK Peterson A R, Binde","year":"2020","unstructured":"Peterson A R, Binde, D. K. Astrocyte glutamate uptake and signaling as novel targets for antiepileptogenic therapy. Front. Neurol. 11, 1006 (2020).","journal-title":"Front. Neurol."},{"key":"97333_CR46","doi-asserted-by":"publisher","first-page":"1335401","DOI":"10.3389\/fonc.2024.1335401","volume":"14","author":"F Lange","year":"2024","unstructured":"Lange, F. et al. A glutamatergic biomarker panel enables differentiating grade 4 gliomas\/astrocytomas from brain metastases. Front. Oncol. 14, 1335401 (2024).","journal-title":"Front. Oncol."},{"key":"97333_CR47","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.omto.2020.12.009","volume":"20","author":"M Wirsching H G, Silgine","year":"2021","unstructured":"Wirsching H G, Silgine, M. Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma. Mol. Ther. Oncolytics 20, 166\u2013174 (2021).","journal-title":"Mol. Ther. Oncolytics"},{"issue":"17","key":"97333_CR48","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.7150\/jca.98449","volume":"15","author":"H Qin","year":"2024","unstructured":"Qin, H. et al. Pan-cancer analysis suggests that LY6H is a potential biomarker of diagnosis, immunoinfiltration, and prognosis. J. Cancer 15(17), 5515\u20135539 (2024).","journal-title":"J. Cancer"},{"issue":"5","key":"97333_CR49","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1073\/pnas.042699899","volume":"99","author":"Gilquinb Fruchart-Gaillard C","year":"2002","unstructured":"Fruchart-Gaillard C, Gilquinb et al. Experimentally based model of a complex between a snake toxin and the alpha 7 nicotinic receptor. Proc. Natl. Acad. Sci. U S A 99(5), 3216\u20133221 (2002).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"97333_CR50","doi-asserted-by":"publisher","first-page":"106698","DOI":"10.1016\/j.phrs.2023.106698","volume":"189","author":"A Becchetti","year":"2023","unstructured":"Becchetti, A. et al. Nicotinic acetylcholine receptors and epilepsy. Pharmacol. Res. 189, 106698 (2023).","journal-title":"Pharmacol. Res."},{"issue":"8","key":"97333_CR51","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1523\/JNEUROSCI.3630-14.2015","volume":"35","author":"M Puddifoot C A, Wu","year":"2015","unstructured":"Puddifoot C A, Wu, M. Ly6h regulates trafficking of alpha7 nicotinic acetylcholine receptors and nicotine-induced potentiation of glutamatergic signaling. J. Neurosci. 35(8), 3420\u20133430 (2015).","journal-title":"J. Neurosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97333-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97333-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97333-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T16:02:11Z","timestamp":1744646531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97333-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["97333"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-97333-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with ethical guidelines and regulations, including the Declaration of Helsinki. Ethical approval for the study was obtained from the Ethics Committee of Fujian Medical University Union Hospital (Approval No.: 2023 KY163). Written informed consent was obtained from all participants and\/or their legal guardians before participation. Participants were fully informed of the study objectives, procedures, risks, and benefits, and were assured of their right to withdraw from the study at any time without any consequences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12833"}}